27th May 2021 09:00
(Alliance News) - AstraZeneca PLC on Thursday said it has priced its issue of EUR800 million in bonds maturing in 2029 with a coupon of 0.375% to help fund its acquisition of Alexion Pharmaceuticals Inc.
The bonds mature on June 3, 2029. The bonds are among those that will be redeemed if the deal to acquire Alexion is not completed by March 2022, AstraZeneca said.
The Cambridge-based pharmaceutical firm is buying Boston, US-based biotech Alexion in a deal worth USD39 billion, with the deal announced back in December. On Tuesday, however, the UK's Competition & Markets Authority said it was investigating the takeover.
The euro-denominated bonds are part of an overall USD7.0 billion bond offer that was announced on Wednesday to fund the purchase of Alexion.
AstraZeneca shares down at 0.1% at 8,012.00 pence each in London on Thursday morning.
By Scarlett Butler; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Astrazeneca